Autologous hematopoietic cell transplantation for adult acute myeloid leukemia: An obsolete or resurfacing concept?
Tài liệu tham khảo
Estey, 2014, Acute myeloid leukemia: 2014 update on risk-stratification and management, Am J Hematol, 89, 1063, 10.1002/ajh.23834
Burnett, 2011, Therapeutic advances in acute myeloid leukemia, J Clin Oncol, 29, 487, 10.1200/JCO.2010.30.1820
Komanduri, 2016, Diagnosis and therapy of acute myeloid leukemia in the era of molecular risk stratification, Annu Rev Med, 67, 59, 10.1146/annurev-med-051914-021329
Niederwieser, 2016, Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey, Bone Marrow Transpl, 51, 778, 10.1038/bmt.2016.18
Gratwohl, 2015, One million haemopoietic stem-cell transplants: a retrospective observational study, Lancet Haematol, 2, e91, 10.1016/S2352-3026(15)00028-9
Cassileth, 1998, Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission, N Engl J Med, 339, 1649, 10.1056/NEJM199812033392301
Nathan, 2004, Consolidation therapy with Autologous bone marrow transplantation in adults with acute myeloid leukemia: a meta-analysis, J Natl Cancer Inst, 96, 38, 10.1093/jnci/djh003
Wang, 2010, Autologous hematopoietic stem Cell transplantation for acute myeloid leukemia in first complete remission: a meta-analysis of randomized trials, Acta Haematol, 124, 61, 10.1159/000314273
Oliansky, 2008, The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myelogenous leukemia in adults: an evidence-based review, Biol Blood Marrow Transpl, 14, 137, 10.1016/j.bbmt.2007.11.002
Ferrara, 2012, Renaissance of autologous stem cell transplantation for AML?, Lancet Oncol, 13, 121, 10.1016/S1470-2045(11)70395-3
Messerer, 2008, Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia, Haematologica, 93, 826, 10.3324/haematol.11987
Sun, 2010, Prevalence and predictors of chronic health Conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study, Blood, 116, 129, 10.1182/blood-2009-06-229369
Gorin, 1977, Autologous bone-marrow transplantation in acute myelocytic leukaemia, Lancet, 1, 1050, 10.1016/S0140-6736(77)91275-2
Yeager, 1986, Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide, N Engl J Med, 315, 141, 10.1056/NEJM198607173150301
To, 1984, High levels of circulating haemopoietic stem cells in very early remission from acute non-lymphoblastic leukaemia and their collection and cryopreservation, Br J Haematol, 58, 399, 10.1111/j.1365-2141.1984.tb03987.x
Schlenk, 1997, Successful collection of peripheral blood progenitor cells in patients with acute myeloid leukaemia following early consolidation therapy with granulocyte colony- stimulating factor-supported high-dose cytarabine and mitoxantrone, Br J Haematol, 99, 386, 10.1046/j.1365-2141.1997.3933207.x
Majhail, 2011, High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR, Bone Marrow Transpl, 46, 385, 10.1038/bmt.2010.115
Keating, 2013, Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research, Haematologica, 98, 185, 10.3324/haematol.2012.062059
Passweg, 2016, Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually, Bone Marrow Transpl, 51, 786, 10.1038/bmt.2016.20
Sanz, 1993, Busulfan plus cyclophosphamide followed by autologous blood stem-cell transplantation for patients with acute myeloblastic leukemia in first complete remission: a report from a single institution, J Clin Oncol, 11, 1661, 10.1200/JCO.1993.11.9.1661
Gorin, 2009, Higher incidence of relapse with peripheral blood rather than marrow as a source of stem cells in adults with acute myelocytic leukemia autografted during the first remission, J Clin Oncol, 27, 3987, 10.1200/JCO.2008.20.1400
Feller, 2003, High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome, Leukemia, 17, 68, 10.1038/sj.leu.2402781
Gorin, 2010, Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission, Blood, 116, 3157, 10.1182/blood-2009-11-252197
Hengeveld, 2015, High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT, Bone Marrow Transpl, 50, 341, 10.1038/bmt.2014.262
Rowley, 1989, Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemia, Blood, 74, 501, 10.1182/blood.V74.1.501.501
Miller, 1991, Correlation of occult clonogenic leukemia drug sensitivity with relapse after autologous bone marrow transplantation, Blood, 78, 1125, 10.1182/blood.V78.4.1125.1125
Cornelissen, 2016, Hematopoietic stem cell transplantation for patients with AML in first complete remission, Blood, 127, 62, 10.1182/blood-2015-07-604546
Cornelissen, 2015, Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years, Leukemia, 29, 1041, 10.1038/leu.2014.332
Pastore, 2015, Next-generation sequencing and detection of minimal residual disease in acute myeloid leukemia: ready for clinical practice?, JAMA, 314, 778, 10.1001/jama.2015.9452
Buckley, 2013, Prognostic and therapeutic Implications of minimal residual disease at the time of transplantation in acute leukemia, Bone Marrow Transpl, 48, 630, 10.1038/bmt.2012.139
Walter, 2011, Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia, J Clin Oncol, 29, 1190, 10.1200/JCO.2010.31.8121
Mulé, 2016, Multigene measurable residual disease assessment improves acute myeloid leukemia relapse risk stratification in autologous hematopoietic cell transplantation, Biol Blood Marrow Transpl, 22, 1974, 10.1016/j.bbmt.2016.08.014
Koreth, 2009, Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials, JAMA, 301, 2349, 10.1001/jama.2009.813
Remberger, 2015, Bone marrow aspiration technique has deteriorated in recent years, Bone Marrow Transpl, 50, 1007, 10.1038/bmt.2015.75
Linker, 2009, Auto- SCT for AML in second remission: CALGB study 9620, Bone Marrow Transpl, 44, 353, 10.1038/bmt.2009.36
Gorin, 2015, Autologous Stem cell transplantation for adult acute leukemia in 2015: time to rethink? Present status and future prospects, Bone Marrow Transpl, 50, 1495, 10.1038/bmt.2015.179